New developments do not bode well for Monsanto.
1. A huge win for consumer activists; Monsanto's Roundup and hundreds of other brands containing glyphosate will soon be labeled a "carcinogen" according to a newly passed California State ruling.
2. An EPA staffer, Jess Rowland, has been accused of colluding with Monsanto to downgrade carcinogenic effects of glyphosate. New York Times article here.
3. Monsanto has been accused of ghostwriting the Roundup cancer studies which show "safety."
4. New studies show that Roundup causes liver disease and glyphosate-based herbicides are decisively linked to cancer in Argentina. Another shows endocrine disruptors such as those found in Roundup and glyphosate-based herbicides are the major contributing factor to the drastic decline of the quality of men's sperm.
5. In a groundbreaking turn of events, Moms Across America has been informed that the EPA has confirmed that The National Toxicology Program will, in fact, assess the final formulation of Glyphosate-based herbicides and the EPA will take their assessment into consideration for their review and decision on whether to renew or revoke the license of glyphosate.
Apparently, Bayer is reconsidering their $66 billion dollar offer to merge....
Could this be the beginning of the end of Monsanto?
See RT.com coverage which includes Zen Honeycutt below:
4反応を表示しています
でサインイン
“For once in your life, listen to me and don’t play your political conniving games with the science to favor the registrants. For once do the right thing and don’t make decisions based on how it affects your bonus.”….
These words, penned in 2013 by former Environmental Protection Agency (EPA) scientist Marion Copley, have an urgency seldom found in the dry correspondence that is typically passed between scientists. But this was no ordinary memo; it was an appeal, a desperate plea for action. And it was written on her death bed.
http://theinternationalforecaster.com/topic/international_forecaster_weekly/monsanto_and_epa_on_the_hot_seat_in_cancer_trial
International Forecaster Weekly
Monsanto and EPA on the Hot Seat in Cancer Trial